The Food and Drug Administration has allowed marketing of a new device that when used along with other assistive devices, like a cane or guide dog, can help orient people who are blind by helping…
Category: News
Cataract culprits
University of Delaware researchers identify genes linked to cataract formationWhen cataracts encroach on the eyes, the only effective remedy is to surgically replace the eyes’ lenses with…
CellResearch receives new patent approval from USPTO for stem cell technology
CellResearch Corporation Pte Ltd, a Singaporean company that specializes in stem cell technology, has received approval for its latest patent on 6 May 2015 from the US Patent and Trademark Office.
Intravitreal Injections and Endophthalmitis
What do we currently know about this complication of intravitreal injections, and how is it best prevented and managed? International Ophthalmology Clinics
Injectable drug ocriplasmin improves vision in patients with symptomatic vitreomacular adhesion
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adh…
Eye’s motion detection sensors identified
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted.But how did your eyes detect that movement? It’s a question that has confounded scientists.
Research finding could help develop artificial retinas for people with vision loss
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It’s a question that has confounded scientists. Now, studying mice, researchers at Washington University Sc…
Bayer HealthCare, Johns Hopkins University to jointly develop new ophthalmic therapies targeting retinal diseases
The Johns Hopkins University and Bayer HealthCare have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The goal of the strategic research alliance is to accelerate the translation…
Avalanche Eye Gene Therapy Meets Safety Goal
Avalanche Biotechnologies Inc’s experimental gene therapy for a leading cause of blindness met its primary safety goal in a small mid-stage trial, while staving off vision loss. Reuters Health Information
CINtec PLUS Cytology test more effective than HC2 HPV test in identifying women with precancerous lesions
Ventana Medical Systems, Inc., a member of the Roche Group, today announced the publication of further results from the Primary ASC-US LSIL Marker Study (PALMS) in this month’s issue of Cancer Cytopathology. The PALMS study, which enrolled more than 27…
ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID™ (Pimavanserin) for Parkinson’s Disease Psychosis at the 19th International Congress of Parkinson’s Disease and Movement Disorders
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the presentation of integrated efficacy and tolerability data from its Phase III program with NUPLAZID™ (pimavanserin) at the 19th International Congress of Parkinson’s Disease and Movement Disorders held in San Diego. “Data from the integrated analysis o
Researchers discover new enzyme, link to iron in vitamin A synthesis
A research team’s discovery of new information about how plants synthesize carotenoids, precursors for vitamin A that are essential for plant development and survival, and human health, could help…
Clearside Biomedical, Inc. Announces Favorable End-of-Phase 2 Review with the FDA
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, Inc., a biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced a favorable End-of-Phase 2 review with the U.S. Food and Drug Admi…
Study highlights discovery of genetic variants linked to mucinous ovarian carcinomas
New research by an international team including Keck Medicine of USC scientists is bringing the origins of ovarian cancer into sharper focus.
Driving Simulator to be Used to Assess Lenses for Cataract Surgery
The University of Iowa is reporting that a new eye lens developed to replace native ones in cataract patients is to be trialed for its novel ability of reducing the halo effect common in current implantable lenses. We’ve written about similar technology, but can’t confirm the same team is behind it. Though the lenses are interesting in (Read more...)
BioLight expands relationship with Ora to develop TeaRx multi-parameter diagnostic test for DES
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, fu…
Ocugen to Present at BIO International Convention
AURORA, Colo.–(BUSINESS WIRE)–Ocugen, Inc. today announced leadership updates and that company Chairman and CEO Dr. Shankar Musunuri will present at BIO International Convention this week in Philadelphia.
Trained Imagers Catch Most Diabetic Retinopathy at Point of Care
Trained nonphysician imagers are able to evaluate patients for diabetic retinopathy in primary care, using a novel technology, ultrawide field imaging, reducing the work load of central reading centers. Medscape Medical News
VENTANA ALK (D5F3) CDx Assay receives FDA approval
Ventana Medical Systems, Inc., a member of the Roche Group, today announced approval of the VENTANA ALK (D5F3) CDx Assay by the US Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer’s FDA approved…
Glaukos Corporation Announces Launch of Initial Public Offering
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation, an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced tod…